ArticleBritish journal of haematology2013

SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.

Maya Koren-Michowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.